Project Details
Description
A Phase 2 Open-Label, Multicenter Clinical Study of the Safety and Efficacy of SNS-595 Injection in Patients at least 60 Years of Age with Previously Untreated Acute Myeloid Leukemia
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/08 → 10/31/11 |
Funding
- Sunesis Pharmaceuticals, Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.